Related Experiment Video
Updated: Jun 5, 2026

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model
Published on: October 16, 2017
RalBP1 is necessary for metastasis of human cancer cell lines
Zhong Wu1, Charles Owens, Nidhi Chandra
1Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA.
Abstract:
RalA expression in human prostate cancer is associated with cell migration and is necessary for bone metastasis. However, the downstream effectors of RalA that mediate these functions remain unclear. Here we examined cell migration after small interfering RNA-mediated depletion of Ral effectors Ral binding protein 1 (RalBP1/RLIP), exocyst complex component 2 (Sec5), and phospholipase D1 (PLD1) and found that RalBP1 and RalA depletion inhibited cell migration to a similar extent. Stable lentivirus short hairpin interfering RNA-mediated depletion of RalA and RalBP1 in PC3 human prostate cancer cells inhibited bone metastasis after intracardiac inoculation. Depletion of RalBP1 diminished orthotopic tumor growth of PC3 cells and inhibited spontaneous metastasis from this site. Interestingly, the expression of wild-type or RalA mutants deficient in RalBP1 binding was effective at rescuing the reduced metastatic capacity of RalA-depleted PC3 cells, suggesting that RalA depletion does not reduce this solely by diminished interaction with RalBP1. To determine whether the role of RalBP1 in metastasis is relevant beyond prostate cancer, we studied the requirement of RalBP1 expression in an experimental metastasis model of human bladder cancer, a tumor type with high RalBP1 expression. Depletion of RalBP1 in UMUC3 cells resulted in decreased lung colonization while having a minimal effect on subcutaneous tumor growth. Our studies are the first to suggest that the expression of RalBP1 is necessary for human cancer cell metastasis. Furthermore, we show that the requirement for RalA expression for manifestation of this phenotype is not entirely dependent on a RalA-RalBP1 interaction.
Insights
RalA and Ral binding protein 1 (RalBP1) are crucial for human cancer cell migration and metastasis. RalBP1 is essential for metastasis in prostate and bladder cancers, independent of its direct interaction with RalA.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- RalA protein expression in human prostate cancer correlates with cell migration and bone metastasis.
- The specific downstream targets of RalA that drive these metastatic processes are not fully understood.
Purpose of the Study:
- To investigate the roles of RalA effectors, specifically Ral binding protein 1 (RalBP1), exocyst complex component 2 (Sec5), and phospholipase D1 (PLD1), in cancer cell migration and metastasis.
- To determine if RalBP1 is essential for metastasis in cancers beyond prostate cancer.
Main Methods:
- Small interfering RNA (siRNA) and short hairpin RNA (shRNA) were used to deplete RalA and its effectors in human prostate cancer (PC3) and bladder cancer (UMUC3) cell lines.
- In vivo studies involved intracardiac inoculation of PC3 cells to assess bone metastasis and orthotopic implantation to evaluate tumor growth and spontaneous metastasis.
- Experimental metastasis models were used to study lung colonization of UMUC3 cells.
Main Results:
- Depletion of RalA and RalBP1 significantly inhibited prostate cancer cell migration and bone metastasis.
- RalBP1 depletion reduced orthotopic tumor growth and spontaneous metastasis of PC3 cells.
- RalBP1 depletion decreased lung colonization in a bladder cancer metastasis model, while having minimal impact on subcutaneous tumor growth.
- Restoring RalA expression with wild-type or RalBP1-binding deficient mutants partially rescued the metastatic capacity of RalA-depleted cells, indicating RalA's function is not solely dependent on RalBP1 interaction.
Conclusions:
- Ral binding protein 1 (RalBP1) is a critical mediator of human cancer cell metastasis in both prostate and bladder cancer.
- RalA's role in promoting metastasis is not entirely dependent on its interaction with RalBP1.
- RalBP1 represents a potential therapeutic target for inhibiting cancer metastasis.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
10:27Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
Related Concept Videos
The Ras Gene
Ras is a superfamily...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation